Close
ACHEMA MIDDLE EAST 2026

Biden Administration Seeks Patents To Cut Medicine Costs

As per the anonymous sources cited by Politico as well as STAT News, the Biden administration has confirmed that it happens to have the...

Innovation-First Mindset: Key To Drive Advanced Therapies

The Advanced Therapies Treatment Centre- ATTC Network has gone on to release a report that stresses the pressing need when it comes to swift...

New Pharma Legislation – Ambitious And Forward-Looking

It is worth noting that political decision-makers at present happen to be under pressure to swiftly accomplish the initial reading of the European Union's...

Factors Influencing Current APAC Biopharma & Healthcare

In the last five years, there have been various local governments in the Asia-Pacific region that have enacted beneficial policies and also regulatory frameworks...

10 Benefits of Digital Transformation In Pharma Production

In the healthcare industry, both patients as well as caregivers share a common desire for the best possible outcome. Technology makes it much easier...

Korean & British Advanced Biotech To Cement Tech Partnership

During South Korean President Yoon Suk Yeol's state visit to the UK, several MoUs were signed between major universities as well as research institutes...

Pharma Spectrum – Using Connected Drug Delivery Devices

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...